Podcasts

Scaling Cell & Gene Therapies: From Breakthroughs to the Mass Market

Invent Life Sciences #S3 Trailer for our next upcoming two part series

In this trailer for our next upcoming two-part series, host Stuart Lowe examines the barriers and breakthroughs that will determine whether cell and gene therapies can scale. From smarter manufacturing to new policy frameworks, join leading experts as they discuss what must change for CGTs to deliver on their full potential.

Join our guests over the next two episodes:

  • Mark Lowdell, Professor at UCL and CSO of INmune Bio
  • Luc Henry, CEO of Limula
  • Jacqui Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult
  • Sarah Albon, Director of Cambridge Cellular Therapy Labratory, Cambridge University Hospitals

Don't want to miss an episode? Subscribe to stay notified of each new episode by searching 'Invent: Life Sciences' on Apple Podcasts, Spotify and Amazon Music.

Talk to us about your next project

Talk to us about your next project

Whether you would like to discuss a project or would like to learn more about our work, get in touch through the form below.

Last Updated
September 11, 2025

You might also like

Talk to us about your next project

We help clients with all stages of their most complex and challenging technology and product development projects.



If you're considering the next steps along your innovation journey, why not get in touch?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

You will occasionally receive expert insights from across our areas of focus and hear directly from our engineers and scientists on the newest developments in the field.

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

Want to work 
at TTP?

Find open positions and contact us to learn more.

Overlay title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

No items found.